Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For patients (both stages of the trial):
- People who are 18 years of age or older
- People who have been diagnosed with advanced (stage IV) non-small cell lung cancer (a specific type of lung cancer)
- People who are currently receiving, or have previously received, a specific type of targeted cancer treatment called a first-line EGFR-TKI (a type of oral medication used for this form of lung cancer — confirm exact details with the trial site)
- People who are able to communicate without significant barriers
- People who show no signs of cognitive difficulties (such as memory or thinking problems) that would prevent them from taking part in an interview or survey, based on an informal check during the screening process
For doctors taking part (Stage 1):
- Doctors who work in cancer treatment, respiratory medicine, or chest surgery departments at large specialist hospitals
- Doctors who regularly treat at least 3 patients per month with advanced non-small cell lung cancer using first-line EGFR-TKI treatment
- Doctors who hold the title of associate chief physician or above
For doctors taking part (Stage 2):
- Doctors who work in cancer treatment, respiratory medicine, or chest surgery departments at large specialist hospitals
- Doctors who regularly treat at least 3 patients per month with advanced non-small cell lung cancer using first-line EGFR-TKI treatment
- Doctors who hold the title of attending physician or above
Who may not be able to join:
- The trial does not list any formal exclusion criteria at this time (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Preferences weights for each attribute level evaluated in the DCE; Relative attribute importance (RAI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.